At its meeting on April 16, 2019, the Board approved $44.6 million to fund 12 studies comparing the best ways to treat a range of health conditions that impose high burdens on patients, caregivers and the healthcare system. Read more about the Board's meeting here.
Among the newly approved awards are four projects focused on improving treatment for people with opioid use disorders. Three of those awards—in Pennsylvania, Massachusetts, and Maryland—focus on patients treated for OUD in doctors’ offices with the medication buprenorphine and seek to determine which psychosocial treatments work best in combination with that medication to help these patients abstain from opioid use. The fourth awarded project, in Connecticut, will compare two approaches for supporting obstetricians who treat pregnant women with OUD with medication-assisted treatment. Other approved funding will support studies on improving prenatal care, treating insomnia and comparing non-drug approaches for treatment of severe pain in patients with cancer.
All PCORI Board meetings are open to the public. This meeting was held via teleconference/webinar with no public comment period.
Catch up on past PCORI Board meetings here.
Approved Minutes of the April 16, 2019 Board Meeting
- Funding Opportunities
- Psychosocial Interventions with Office-Based Opioid Treatment for Opioid Use Disorder -- Cycle 2 2018
- Medication-Assisted Treatment (MAT) Delivery for Pregnant Women with Substance Use Disorders Involving Prescription Opioids and/or Heroin -- Cycle 2 2018
- Symptom Management for Patients with Advanced Illness -- Cycle 2 2018
- Improving Methods for Conducting Patient-Centered Outcomes Research -- Cycle 2 2018
- Broad PCORI Funding Announcements -- Cycle 2 2018
- Advisory Panels
- Governance Committees